title: Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma.
abstract: A localized left breast ductal invasive triple-negative breast carcinoma (TNBC) was diagnosed in a 44-year-old woman. After surgery, she was treated with chemotherapy and radiation therapy in accordance with national guidelines. At the end of treatment, she had local and metastatic relapse with multiple sub-diaphragmatic lymph nodes.
authors: Guilhem
authors: G
authors: Bousquet
authors: Jean-Paul
authors: JP
authors: Feugeas
authors: Irmine
authors: I
authors: Ferreira
authors: Laetitia
authors: L
authors: Vercellino
authors: Nathalie
authors: N
authors: Jourdan
authors: Philippe
authors: P
authors: Bertheau
authors: Cédric
authors: C
authors: de Bazelaire
authors: Emmanuel
authors: E
authors: Barranger
authors: Anne
authors: A
authors: Janin
mesh_terms: D000328:Adult; D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068818:Cetuximab; D002945:Cisplatin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D000077143:Docetaxel; D015251:Epirubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015674:Mammary Neoplasms, Animal / Q000188:drug therapy*; D051379:Mice; D009362:Neoplasm Metastasis / Q000188:drug therapy* / Q000235:genetics; D009368:Neoplasm Transplantation; D017239:Paclitaxel / Q000627:therapeutic use; D043823:Taxoids / Q000627:therapeutic use; D014183:Transplantation, Heterologous; D016896:Treatment Outcome; D064726:Triple Negative Breast Neoplasms / Q000235:genetics / Q000628:therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D043823:Taxoids; D000077143:Docetaxel; D015251:Epirubicin; D003520:Cyclophosphamide; D017239:Paclitaxel; D000068818:Cetuximab; D002945:Cisplatin